Monday 15 October 2018
Contact US    |    Archive
Reuters
25 days ago

Lilly migraine drug wins European panel thumbs-up

A European Medicines Agency panel on Friday recommended the approval of U.S. pharmaceutical group Eli Lilly s migraine treatment, bringing the drug one step closer to being sold in the European Union.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Lilly

 | 

migraine

 | 

drug

 | 

wins

 | 

European

 | 

panel

 | 

thumbs

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)